{
  "docId": "019de075-14f9-764d-9ac8-e183992152e6",
  "docSlug": "6a6376e4d61d0db2f29d5d862e5685f7",
  "documentTitle": "argenx SE | Investor Presentation Deck | 22 slides",
  "authorId": "argenx-se",
  "authorName": "argenx",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-06-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 12,
  "pageCount": 22,
  "prevPage": 11,
  "nextPage": 13,
  "slideType": "thesis_headline",
  "function": "establish_context",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "The slide uses a hub-and-spoke visual metaphor to link the clinical class to the specific biological targets.",
  "elementsJson": null,
  "metadataConfidence": 0.9,
  "imagePath": null,
  "slideHref": "/slides/019de075-14f9-764d-9ac8-e183992152e6/12",
  "deckHref": "/decks/019de075-14f9-764d-9ac8-e183992152e6",
  "deckJsonHref": "/decks/019de075-14f9-764d-9ac8-e183992152e6.json",
  "deckAnchorHref": "/decks/019de075-14f9-764d-9ac8-e183992152e6#slide-12",
  "components": [
    {
      "bbox": {
        "h": 0.35,
        "w": 0.25,
        "x": 0.07,
        "y": 0.38
      },
      "kind": "callout",
      "text": "clinical Pioneer FcRn class of medicines",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cfc63ba2-0b8d-4500-9fd2-ac65d9d0af73",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.65,
        "w": 0.86,
        "x": 0.07,
        "y": 0.25
      },
      "kind": "diagram",
      "text": "Clinical Pioneer FcRn class of medicines connected to a list of autoantibodies including Contactin1, Ro/SSA, Mi-2, DSG-1, THSd7A, MPO-ANCA, La/SSB, ANA, NF155, PLA2R, GPIIb/IIIa, HMGCR, DSG-3, DSA, NELL1, BP230, PR3-ANCA, GPCR, AChR, BP180, LRP4, MuSK, JO-1, SRP, TSHR, Immune complexes",
      "attrs": null,
      "subkind": "hub-spoke",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bc561be4-880f-4daa-bd37-cd77c5f53458",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.55,
        "x": 0.03,
        "y": 0.03
      },
      "kind": "title",
      "text": "IgG Autoantibodies Serve as Unifying Biology Rationale for POC Indications",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a48a51c8-4fb3-4f72-a4bb-ca339367012a",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "hub-spoke",
      "slug": null,
      "matchId": "1affafb6-768a-414d-a365-181ad42d8de2",
      "evidence": "Visual layout showing a central clinical class connecting to multiple peripheral autoantibody targets.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 19,
      "from": 11,
      "beatId": "14154d6d-3761-4292-8d0e-2a584e4be20e",
      "arcName": "The Sparkline",
      "arcSlug": "sparkline",
      "beatName": "Roadmap",
      "beatSlug": null,
      "evidence": "Outlining global launch progress, pipeline, and catalysts for growth.",
      "position": 4,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}